Literature DB >> 15607210

An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients.

Makoto Sohmiya1, Makoto Tanaka, Yoko Suzuki, Yutaka Tanino, Koichi Okamoto, Yorihiro Yamamoto.   

Abstract

We have compared plasma redox status of coenzyme Q-10 in 20 sporadic amyotrophic lateral sclerosis (sALS) patients with those in 20 healthy age/sex-matched controls. A significant increase in the oxidized form of coenzyme Q-10 (sALS=109.3+/-95.2 nM; controls=23.3+/-7.5 nM, P=0.0002) and in the ratio of oxidized form of coenzyme Q-10 to total coenzyme Q-10 (%CoQ-10) (sALS=12.0+/-9.3%; controls=3.2+/-0.9%, P<0.0001) were observed. Moreover, %CoQ-10 correlated significantly with the duration of illness (rho=0.494, P=0.0315). Our finding suggests systemic oxidative stress in the pathogenesis of sALS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15607210     DOI: 10.1016/j.jns.2004.09.030

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  20 in total

Review 1.  Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease.

Authors:  Christi Kolarcik; Robert Bowser
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

Review 2.  Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

Authors:  Emanuele D'Amico; Pam Factor-Litvak; Regina M Santella; Hiroshi Mitsumoto
Journal:  Free Radic Biol Med       Date:  2013-06-21       Impact factor: 7.376

3.  An exploratory study of serum urate levels in patients with amyotrophic lateral sclerosis.

Authors:  Stefano Zoccolella; Isabella Laura Simone; Rosa Capozzo; Rosanna Tortelli; Antonio Leo; Eustachio D'Errico; Giancarlo Logroscino
Journal:  J Neurol       Date:  2010-09-15       Impact factor: 4.849

4.  Increased oxidative stress in patients with amyotrophic lateral sclerosis and the effect of edaravone administration.

Authors:  Midori Nagase; Yorihiro Yamamoto; Yusuke Miyazaki; Hiide Yoshino
Journal:  Redox Rep       Date:  2016-02-25       Impact factor: 4.412

5.  Oxidative stress in Niemann-Pick disease, type C.

Authors:  Rao Fu; Nicole M Yanjanin; Simona Bianconi; William J Pavan; Forbes D Porter
Journal:  Mol Genet Metab       Date:  2010-07-27       Impact factor: 4.797

Review 6.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

7.  Coenzyme Q10 effects in neurodegenerative disease.

Authors:  Meredith Spindler; M Flint Beal; Claire Henchcliffe
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-16       Impact factor: 2.570

Review 8.  Nutrition and dietary supplements in motor neuron disease.

Authors:  Jeffrey Rosenfeld; Amy Ellis
Journal:  Phys Med Rehabil Clin N Am       Date:  2008-08       Impact factor: 1.784

Review 9.  Biomarkers in amyotrophic lateral sclerosis: facts and future horizons.

Authors:  Pierre-François Pradat; Michel Dib
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

10.  Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.

Authors:  Petra Kaufmann; John L P Thompson; Gilberto Levy; Richard Buchsbaum; Jeremy Shefner; Lisa S Krivickas; Jonathan Katz; Yvonne Rollins; Richard J Barohn; Carlayne E Jackson; Ezgi Tiryaki; Catherine Lomen-Hoerth; Carmel Armon; Rup Tandan; Stacy A Rudnicki; Kourosh Rezania; Robert Sufit; Alan Pestronk; Steven P Novella; Terry Heiman-Patterson; Edward J Kasarskis; Erik P Pioro; Jacqueline Montes; Rachel Arbing; Darleen Vecchio; Alexandra Barsdorf; Hiroshi Mitsumoto; Bruce Levin
Journal:  Ann Neurol       Date:  2009-08       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.